Á¦21ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2021-07-09±³À°ÀÏÀÚ : 2021-07-09
±³À°Àå¼Ò : ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-2·ë
±³À°ÁÖÁ¦ :
Á¦21ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ
´ã´çÀÚ : ±èÈ£Á¤
¿¬¶ôó : 055-910-2187
À̸ÞÀÏ :
ksimd2014@naver.com ±³À°Á¾·ù : ³»°ú, ¼Ò¾Æû¼Ò³â°úÀÇ»çÇÐ, »ýÈÇÐ, ¾à¸®ÇÐ
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 70,000¿ø
ºñ°í »çÀüµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 4¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 3¸¸¿ø, ±âŸ 4¸¸¿ø »çÀüµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 6¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 5¸¸¿ø, ±âŸ 6¸¸¿ø ÇöÀåµî·Ï(ȸ ¿ø): Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 4¸¸¿ø, ±âŸ 5¸¸¿ø ÇöÀåµî·Ï(ºñȸ¿ø): Àü¹®ÀÇ 7¸¸¿ø, Àü°øÀÇ ¶Ç´Â Çлý 6¸¸¿ø, ±âŸ 7¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-2·ë 10:00~10:40 Brain organoid model of IMD °°æ¼±(¼¿ï´ë¼öÀÇÇаú)
Åä·Ð 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-4·ë 10:40~11:20 oral presentation ()
ÈÞ½Ä 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-11·ë 11:20~11:40 Coffee break ()
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-3·ë 11:40~12:20 Çѱ¹Ã·´ÜÀç»ýÀÇ·áÀÇ Àü¸Á°ú ¹æÇâ ¿ÀÀÏȯ(Ä«Å縯ÀÇ´ë)
½Ä»ç 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-5·ë 12:20~13:20 ½Ä»ç ()
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-6·ë 13:20~13:50 RNA Therapy: Current Status and Future Potential in IMD ±è¿µ±¹(Àü³²ÀÇ´ë)
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-7·ë 13:50~14:20 Nanomedicine-Based Therapeutics in IMD ÁÖÁø¸í(UNIST)
Åä·Ð 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-8·ë 14:20~15:00 oral presentation ()
ÈÞ½Ä 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-11·ë 15:00~15:20 Coffee break ()
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-9·ë 15:20~15:50 Long-term therapies for mitochondrial diseases: supportive therapy to current clinical trials ÀÌ¿µ¸ñ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-10·ë 15:50~16:20 Organic acidurias: new challenging and novel concept Shirou Mastumoto(Kumamoto University)
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-12·ë 16:20~16:50 Clinical value and barriers to clinical adoption of NGS panel for IMD ±ââ¼®(GC³ì½ÊÀÚ Áö³ð)
±³À°½Ã°£ 07-09 ±×·£µåÇϾæƮȣÅÚ 2Ãþ ³²»ê1-13·ë 16:50~17:20 NEOseq-ACTION for IMD ¼º¹®¿ì(¼¿ïÀÇ´ë)